Analysis on the Influence of Policy Factors in Innovating Behavior for Chinese Orphan Drugs’ Industry

Baxian Yi, Guangping Wang, Yanfei Huo, Xiaoming Wu

Abstract


Because of the small target market and poor profitability of Orphan Drug, it is difficult to effectively encourage the R&D and production Behavior of the Industry by the market mechanisms alone. So that, it is necessary to implement the incentive policy for Orphan Drug in order to stimulate the innovative behavior. Basing on the analysis of domestic market and foreign and innovative incentives policy, the paper discussed the policy factors of the innovative behavior for Chinese Orphan Drugs’ industry by the research method of Structural Equation Modeling (SEM), and proposed the innovation incentive path, such as the registered priorities policy, industry-led incentive, new medical reform policy, and the policies collaborative mechanism.

Full Text:

PDF


DOI: https://doi.org/10.5539/par.v3n2p134

Refbacks

  • There are currently no refbacks.


Copyright (c)



Public Administration Research  ISSN 1927-517X  (Print)  ISSN 1927-5188  (Online)  Email: par@ccsenet.org

Copyright © Canadian Center of Science and Education

To make sure that you can receive messages from us, please add the 'ccsenet.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.